1-8 of 8
hospitals, high-volume
Close
Sort by
Journal Articles

Acute Healthcare Utilization and Predictors of Admission for Sickle Cell Disease in Illinois

Christina M Barriteau, MD, Mariam Kayle, PhD RN, Joseph M Feinglass, PhD, Paige VonAchen, BA, Robert I Liem, MD MS, Sherif M. Badawy, MD, Kristin Kan, MDMPH,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 2107.
https://doi.org/10.1182/blood-2019-128150
Published: 2019
Journal Articles

Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Population-Based Study

Amer M. Zeidan, MBBS, MHS, Nikolai A. Podoltsev, MD PhD, Xiaoyi Wang, MD MPH, Jan Philipp Bewersdorf, MD, Rory M Shallis, MD, Scott F. Huntington, MD MPH, Natalia Neparidze, MD, Smith Giri, MBBS, MHS, Steven D. Gore, MD, Xiaomei Ma, PhD, Amy J Davidoff, PhD MS, Rong Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 116.
https://doi.org/10.1182/blood-2019-126643
Published: 2019
Journal Articles

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Binod Dhakal, MBBS, Smith Giri, MBBS, Adam Levin, MD, Rein Lisa, Timothy S. Fenske, MD, Saurabh Chhabra, MD, Nirav N Shah, MD, Aniko Szabo, PhD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD, Mehdi Hamadani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 617.
https://doi.org/10.1182/blood-2018-99-116196
Published: 2018
Journal Articles

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Binod Dhakal, MBBS, Smith Giri, MBBS, Adam Levin, MD, Rein Lisa, Timothy S. Fenske, MD, Saurabh Chhabra, MD, Nirav N Shah, MD, Aniko Szabo, PhD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD, Mehdi Hamadani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3544.
https://doi.org/10.1182/blood-2018-99-118873
Published: 2018
Journal Articles

CML Treatment in Dutch Hospitals with Low Patient Volumes Is Associated with a Substandard Quality of Molecular Response Monitoring

Inge G.P. Geelen, MD, Noortje Thielen, MD PhD, Jeroen J.W.M. Janssen, MD PhD, Tanja Roosma, Otto Visser, MD PhD, Jan J. Cornelissen, MD PhD, Peter E. Westerweel, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1913.
https://doi.org/10.1182/blood.V128.22.1913.1913
Published: 2016
Journal Articles

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Roberto A. Ferro, MD, Valerie Shostrom, MS, Julie M. Vose, MD, Krishna Gundabolu, MD, Smith Giri, MBBS, KM Monirul Islam, MDPhD, Lori J. Maness, MD, James Olen Armitage, MD, Vijaya R. Bhatt, MD
Journal: Blood
Blood (2015) 126 (23): 268.
https://doi.org/10.1182/blood.V126.23.268.268
Published: 2015
Journal Articles

Pediatric Hospital Volume and Induction Mortality in Pediatric Acute Lymphoblastic Leukemia (ALL)

Jennifer J. Wilkes, MD, Sean Hennessy, PharmD PhD, Rui Xiao, PhD, Susan R. Rheingold, MD, Alix E. Seif, MD MPH, Yuan-Shung Huang, MS, Neika Vendetti, MPH, Yimei Li, PhD, Rochelle Bagatell, MD, Richard Aplenc, MD PhD, Brian T. Fisher, DO, MSCE
Journal: Blood
Blood (2014) 124 (21): 2653.
https://doi.org/10.1182/blood.V124.21.2653.2653
Published: 2014
Journal Articles

Quality of Care in Hospitalizations for Sickle Cell Disease in the U.S.: Do Low Patient Volumes Mean Higher Mortality?

Timothy L McCavit, MD, Song Zhang, Ph.D., Chul Ahn, Ph.D., Glenn Flores, M.D., Charles T Quinn, M.D.
Journal: Blood
Blood (2008) 112 (11): 166.
https://doi.org/10.1182/blood.V112.11.166.166
Published: 2008